Strides Pharma News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Strides Pharma Science Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Strides Pharma Science Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Strides Pharma from all sources in a single place.

Strides Pharma Science Ltd.

29 Dec 2025

941.85

-2.70%

ChinaAMC lists depository receipts of two flagship ETFs on Thai exchange

Business Standard

/ -- Today, China Asset Management Co. (ChinaAMC) partnered with Thai securities firm InnovestX Securities to list Depository Receipts (DRs) linked to the "ChinaAMC CSI 300 ETF" and the "ChinaAMC STAR 50 ETF" on the Stock Exchange of Thailand (SET), enabling Thai investors access to a basket of China's core assets and hard-core technologies. This marks the first time that ETFs listed on the Shanghai Stock Exchange (SSE) have entered an overseas market through a DR structure, and represents another milestone in deepening capital market cooperation between China and Thailand under the Belt and Road Initiative. The simultaneous listing of these two flagship ETFs in Thailand also fully reflects the local market's strong interest in allocating to high-quality Chinese assets and their confidence toward growth prospects of China's technology sector. In June, ChinaAMC collaborated with Thailand's leading asset manager BBL Asset Management to launch the Southeast Asian nation's first feeder

Number of FII/FPI investors decreased from 287 to 275 in Sep 2025 qtr

Strides Pharma Science Ltd.

24 Dec 2025

941.85

-2.70%

Company Update

Strides Pharma Science Ltd - 532531 - Completion Of US-FDA Inspection At The Formulations Facility Of …

BSE India

Completion of US-FDA Inspection at Formulations Facility of Strides Pharma Inc.

pdf

Strides Pharma Science Ltd.

22 Dec 2025

941.85

-2.70%

SAST

Strides Pharma Science Ltd - 532531 - Closure of Trading Window

BSE India

Intimation regarding closure of trading window for the quarter and nine months ended December 31, 2025

pdf

Strides Pharma Science Ltd.

03 Dec 2025

941.85

-2.70%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under reg 30 - Resignation of Group CHRO

pdf

Strides Pharma Science Ltd.

17 Nov 2025

941.85

-2.70%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Schedule of Analyst/ Institutional Investor''s Meet

pdf

Strides Pharma Science Ltd.

11 Nov 2025

941.85

-2.70%

STRIDES PHARMA SCIENCE LIMITED

Accumulate: Strides Pharma Science Ltd.

Recommendation Target

Geojit BNP Paribas

Management remains optimistic about performance in other regulated markets, anticipating stronger revenue growth in FY26 as European partners prepare for product launches. The company also expects these markets to eventually generate...

Strides Pharma Science Ltd. is trading above all available SMAs

Strides Pharma Science Ltd.

01 Nov 2025

941.85

-2.70%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement - Unaudited financial results of the Company for the quarter and half year ended September 30, 2025

pdf

Strides Pharma Science Ltd.

31 Oct 2025

941.85

-2.70%

Strides Pharma Science Q2 net profit jumps 82% at 131.5 crore

Business Line

The company had posted a consolidated net profit of 72.3 crore in the corresponding period last fiscal, Strides Pharma Science said in a regulatory filing